Search form



CL Mobile Menu

Payal Kohli, MD

Payal Kohli, MD

Dr Kohli is a graduate of Harvard Medical School, where she received a magna cum laude distinction. She completed a residency in Internal Medicine at Harvard Medical School/Brigham & Women’s hospital and a fellowship in cardiovascular diseases at the University of California San Francisco. Currently she is in practice with a cardiovascular medicine group in Denver, Colorado.




Posts by Author

Does coffee increase AF risk? How about chocolate? Marijuana? Test yourself with our quiz so you can counsel your patients.

Mr Smith is 66-years-old. How would you treat his arrhythmia? What would you choose for anticoagulation?

Digoxin is used in nearly 30% of patients with AF but has never been studied for safety/efficacy in this population, until now.

Some call this new study a "game changer" when it comes to AF patient selection for direct-acting oral anticoagulant Rx. What's your take?

Is exercise safe in HF patients who have AF? Results of the HF-ACTION study are summarized in this short slide show.

A study of a global registry finds that prescriptions for direct oral anticoagulants have now surpassed those for VKAs. What do you Rx?

Patients who require dose adjustment when taking direct oral anticoagulants have not been well studied. This large study is a good start.

In these complicated patients, should warfarin or a novel oral anticoagulant be chosen for stroke prevention?

Is aspirin safe as antithrombotic therapy in pregnancy? Is electrocardioversion first-line treatment? Get the answers and other reminders, here.

Answers to 5 simple questions about your patient and the pending procedure create a pathway to decisions about perioperative anticoagulation.


By clicking Accept, you agree to become a member of the UBM Medica Community.